Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

NCT00406393 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

304

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myelocytic, Acute
Leukemia, Lymphocytic, Acute
Leukemia, Myeloid, Chronic
Myelodysplastic Syndromes

Interventions

DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: Sirolimus

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]